瑞士種子公司先正達

ChemChina has tendered about 95 per cent of the shares in Swiss seedmaker Syngenta, drawing closer to the finish line the $44bn deal that will transform China into an agrichemical powerhouse.

瑞士種子公司先正達(Syngenta)約95%的股份已接受中國化工(ChemChina)的收購要約，這筆規模達440億美元、將把中國變成農化強國的交易已接近完成。

Announcing the definitive end results for its offer on the company, ChemChina said it planned to continue to buy shares in order to push its holdings above a required 98 per cent in Syngenta, at which point it can cancel outstanding shares.

中國化工在宣佈其收購要約的明確最終結果時表示，它打算繼續收購先正達股份，以使持股比例超過98%。超過這一比例，中國化工就能要求註銷餘下的先正達股份。

The cross-border buyout, China’s largest to date, has dragged on since it was first announced in February last year, hitting several regulatory snags in Europe as well as concerns over ChemChina’s ability to pay for Syngenta.

自去年2月首次公佈消息以來，這宗中國企業迄今規模最大的跨境併購案已拖延了很久，在歐洲遭遇幾次監管障礙，其是否有能力支付收購先正達的款項也曾引發擔憂。

ChemChina allayed some concerns over the longer-term financing for the deal were last week when it announced that it had issued $20bn in perpetual bonds and preference shares to pay for acquisition.

上週，中國化工宣佈已通過發行永續債和優先股籌資200億美元，用於支付收購款，這在一定程度上化解了外界對於該交易較長期融資的擔憂。